Please go to the PowerPak homepage
and select a course.
Module 1. Diabetes Defined: An Overview of Prevalence and Pathophysiology
This activity is for pharmacists and is sponsored by Postgraduate Healthcare Education, LLC (PHE).
There has been no commercial support for this activity.
Ashley A. Martin, PharmD, CDE
Clinical Pharmacy Specialist, Diabetes
Providence Endocrinology, Diabetes and Nutrition Center
Terri Warholak, PhD, RPh, FAPhA
DIABETES PROGRAM PLANNER
Susan Sloane, RPh, CDE, CPT
CLINICAL REVIEWER FOR UPDATES
Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP
Vice-Chair & Allen I. White Distinguished Associate Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
EDITORIAL REVIEWER FOR UPDATES
Laura K. Stinson, PharmD
Ashley A. Martin, PharmD, CDE, has no relevant affiliations or financial relationships with a commercial interest to disclose.
Terri Warholak, PhD, RPh, FAPhA has no relevant affiliations or financial relationships with a commercial interest to disclose.
The following reviewers, Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP and Laura K. Stinson, PharmD, have no relevant affiliations or financial relationships with a commercial interest to disclose.
Susanne Batesko, RN, BSN, Robin Carrino, and Susan Sloane, RPh, CDE, CPT, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credits: 2.0 hours (0.20 ceu)
Type of Activity: Knowledge
Fee Information: Fee is included in the Pharmacist Diabetes MTM Certificate Program or $6.97 per course.
Estimated time to complete activity: 120 minutes
May 2, 2019
May 2, 2022
This accredited activity has been designed for pharmacists.
This course was originally released May 1, 2016 under UAN #0430-0000-16-022-H01-P. Updates were provided throughout the accreditation period. May 2, 2019 additional updates provided to ensure medical accuracy/timely information and released under UAN#0430-0000-19-031-H01-P.
HOW TO EARN CREDIT
During the period May 2, 2019 through May 2, 2022 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
The goal of this CE module is to provide pharmacists with a complete understanding of the pathophysiology of type 1 and type 2 diabetes, the clinical features of the disease and the progressive nature of type 2 diabetes.
Upon completion of this activity, participants should be better able to:
- Recognize the prevalence of diabetes and diabetes-related complications;
- Discuss key factors in the pathogenesis of type 1 diabetes (T1D) and type 2 diabetes (T2D);
- Review symptoms and risk factors for both T1D and T2D; and
- State key counseling points related to the pathophysiology of diabetes.
REQUIRED COMPUTER HARDWARE/SOFTWARE
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5
Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.